Study: Many non-oncologic surrogate markers lack meta-analyses linking them to outcomes | RAPS
Over half of the non-oncologic surrogate markers listed in the US Food and Drug Administration@s (FDA) Adult Surrogate Endpoint Table do not have a meta-analysis of clinical trials evaluating the relationship between the treatment effect associated with the marker and a clinical outcome, according to a recent study published in JAMA.